Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Jeffrey Sparks MD, MMSc

Jeffrey A. Sparks MD, MMSc

Assistant Professor of Medicine, Harvard Medical School; Director of Immuno-Oncology and Autoimmunity; Director of Mentorship, Rheumatology Fellowship Program, Division of Rheumatology, Inflammation, and Immunity, Brigham and Women’s Hospital, Boston, Massachusetts

Jeffrey A. Sparks, MD, MMSc, is a rheumatologist and Assistant Professor of Medicine at Brigham and Women’s Hospital and Harvard Medical School in Boston, Massachusetts. His research focuses on using patient-oriented and epidemiologic methods to evaluate the etiology, outcomes, and public health burden of rheumatic diseases.

Disclosures

Dr. Sparks is supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (grant numbers R01 AR077607, P30 AR070253, and P30 AR072577) and the R. Bruce and Joan M. Mickey Research Scholar Fund. Dr. Sparks has received research support from Bristol Myers Squibb and performed consultancy for AbbVie, Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Gilead, Inova Diagnostics, Janssen, Optum, and Pfizer unrelated to this work.

Recent Contributions to PracticeUpdate:

  1. GLORIA Trial: Low Dose, Add-On Prednisolone for Rheumatoid Arthritis
  2. TREAT EARLIER Study: An Overview
  3. COVID and the Patient With Rheumatoid Arthritis
  4. Managing Rheumatoid Arthritis in the Primary Care Setting
  5. 2021 Rheumatoid Arthritis Treatment Guidelines
  6. Effect of Methotrexate Discontinuation in RA Patients Vaccinated With Inactivated SARS-CoV-2 Vaccine

Recently Updated